NO305439B1 - Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse - Google Patents
Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disseInfo
- Publication number
- NO305439B1 NO305439B1 NO954317A NO954317A NO305439B1 NO 305439 B1 NO305439 B1 NO 305439B1 NO 954317 A NO954317 A NO 954317A NO 954317 A NO954317 A NO 954317A NO 305439 B1 NO305439 B1 NO 305439B1
- Authority
- NO
- Norway
- Prior art keywords
- pct
- quinoxaline derivatives
- pyrido
- sec
- halogen
- Prior art date
Links
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- -1 -POXY Inorganic materials 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4314593A DE4314593A1 (de) | 1993-04-28 | 1993-04-28 | Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln |
PCT/DE1994/000494 WO1994025472A1 (de) | 1993-04-28 | 1994-04-28 | Pyrido[1,2,3-de]chinoxalinderivate, verfahren zu deren herstellung und ihre verwendung in arzneimitteln |
Publications (3)
Publication Number | Publication Date |
---|---|
NO954317D0 NO954317D0 (no) | 1995-10-27 |
NO954317L NO954317L (no) | 1995-12-28 |
NO305439B1 true NO305439B1 (no) | 1999-05-31 |
Family
ID=6487060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954317A NO305439B1 (no) | 1993-04-28 | 1995-10-27 | Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse |
Country Status (22)
Country | Link |
---|---|
US (1) | US5750526A (pl) |
EP (1) | EP0696291B1 (pl) |
JP (1) | JPH09500359A (pl) |
KR (1) | KR960701885A (pl) |
CN (1) | CN1043576C (pl) |
AT (1) | ATE169925T1 (pl) |
AU (1) | AU686160B2 (pl) |
CA (1) | CA2161427A1 (pl) |
CZ (1) | CZ277795A3 (pl) |
DE (2) | DE4314593A1 (pl) |
DK (1) | DK0696291T3 (pl) |
ES (1) | ES2122274T3 (pl) |
FI (1) | FI955141A0 (pl) |
HU (1) | HUT74173A (pl) |
IL (1) | IL109396A (pl) |
NO (1) | NO305439B1 (pl) |
NZ (1) | NZ265600A (pl) |
PL (1) | PL174418B1 (pl) |
RU (1) | RU2140924C1 (pl) |
SK (1) | SK131995A3 (pl) |
WO (1) | WO1994025472A1 (pl) |
ZA (1) | ZA942970B (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0903144A4 (en) * | 1996-04-17 | 2001-10-31 | Sumitomo Pharma | MEDICINE FOR RETINAL NEUROPATHY |
US6063774A (en) * | 1996-12-16 | 2000-05-16 | Warner-Lambert Company | Tricyclic quinoxaline derivatives as neuroprotective agents |
CN113620890B (zh) * | 2020-05-07 | 2024-06-28 | 普济生物科技(台州)有限公司 | 苯并喹喔啉酮化合物及其合成方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2955358B2 (ja) * | 1989-06-09 | 1999-10-04 | ファルマシア・アンド・アップジョン・カンパニー | 中枢神経系活性を有する複素環系アミン |
US5273975A (en) * | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
JPH05117276A (ja) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | 新規な3環性キノキサリンジオン誘導体 |
-
1993
- 1993-04-28 DE DE4314593A patent/DE4314593A1/de not_active Withdrawn
-
1994
- 1994-04-22 IL IL109396A patent/IL109396A/xx not_active IP Right Cessation
- 1994-04-28 DE DE59406739T patent/DE59406739D1/de not_active Expired - Lifetime
- 1994-04-28 KR KR1019950704707A patent/KR960701885A/ko not_active Application Discontinuation
- 1994-04-28 HU HU9502810A patent/HUT74173A/hu unknown
- 1994-04-28 CZ CZ952777A patent/CZ277795A3/cs unknown
- 1994-04-28 AT AT94914314T patent/ATE169925T1/de not_active IP Right Cessation
- 1994-04-28 PL PL94311295A patent/PL174418B1/pl unknown
- 1994-04-28 NZ NZ265600A patent/NZ265600A/en unknown
- 1994-04-28 ZA ZA942970A patent/ZA942970B/xx unknown
- 1994-04-28 WO PCT/DE1994/000494 patent/WO1994025472A1/de not_active Application Discontinuation
- 1994-04-28 SK SK1319-95A patent/SK131995A3/sk unknown
- 1994-04-28 RU RU95119828A patent/RU2140924C1/ru active
- 1994-04-28 AU AU66756/94A patent/AU686160B2/en not_active Ceased
- 1994-04-28 CN CN94191912A patent/CN1043576C/zh not_active Expired - Fee Related
- 1994-04-28 US US08/535,250 patent/US5750526A/en not_active Expired - Fee Related
- 1994-04-28 DK DK94914314T patent/DK0696291T3/da active
- 1994-04-28 ES ES94914314T patent/ES2122274T3/es not_active Expired - Lifetime
- 1994-04-28 CA CA002161427A patent/CA2161427A1/en not_active Abandoned
- 1994-04-28 JP JP6523752A patent/JPH09500359A/ja active Pending
- 1994-04-28 EP EP94914314A patent/EP0696291B1/de not_active Expired - Lifetime
-
1995
- 1995-10-27 NO NO954317A patent/NO305439B1/no unknown
- 1995-10-27 FI FI955141A patent/FI955141A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
DE59406739D1 (de) | 1998-09-24 |
ATE169925T1 (de) | 1998-09-15 |
JPH09500359A (ja) | 1997-01-14 |
HUT74173A (en) | 1996-11-28 |
HU9502810D0 (en) | 1995-11-28 |
PL311295A1 (en) | 1996-02-05 |
ES2122274T3 (es) | 1998-12-16 |
DK0696291T3 (da) | 1999-05-25 |
EP0696291A1 (de) | 1996-02-14 |
WO1994025472A1 (de) | 1994-11-10 |
CN1043576C (zh) | 1999-06-09 |
IL109396A (en) | 1997-11-20 |
DE4314593A1 (de) | 1994-11-03 |
AU686160B2 (en) | 1998-02-05 |
KR960701885A (ko) | 1996-03-28 |
PL174418B1 (pl) | 1998-07-31 |
NZ265600A (en) | 1996-09-25 |
AU6675694A (en) | 1994-11-21 |
NO954317L (no) | 1995-12-28 |
RU2140924C1 (ru) | 1999-11-10 |
SK131995A3 (en) | 1996-07-03 |
FI955141A (fi) | 1995-10-27 |
NO954317D0 (no) | 1995-10-27 |
FI955141A0 (fi) | 1995-10-27 |
IL109396A0 (en) | 1994-07-31 |
CA2161427A1 (en) | 1994-11-10 |
CN1121720A (zh) | 1996-05-01 |
US5750526A (en) | 1998-05-12 |
CZ277795A3 (en) | 1996-02-14 |
EP0696291B1 (de) | 1998-08-19 |
ZA942970B (en) | 1995-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2639636B1 (fr) | Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant | |
ATE51231T1 (de) | Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als antiallergische mittel. | |
HUP0204354A2 (hu) | Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
PT902684E (pt) | Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos | |
NO305439B1 (no) | Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse | |
FI970434A0 (fi) | Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä | |
NO306781B1 (no) | Imidazo[1,2-a]kinoksalinforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter | |
AU2001261707A1 (en) | Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives | |
DK0772615T3 (da) | Imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylsyrederivater, fremstilling af disse forbindelser og lægemidler indeholdende d | |
ATE212634T1 (de) | Metalloproteaseinhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
IL67400A (en) | Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them | |
NO305519B1 (no) | Benzo[f]kinoksalindionderivater og legemidler inneholdende disse | |
ES2122521T3 (es) | Derivados de 2'-desoxi-5-fluorouridina y sus sales farmaceuticamente aceptables, procedimiento para su preparacion y agentes antitumorales. | |
ATE254608T1 (de) | Substituierte 2,3-benzodiazepinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische präparate sowie ihre verwendung | |
TH35763A (th) | ควิโนลีนและสารประกอบควินาโชลีนที่ใช้ประโยชน์ในการรักษา |